Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Quest Diagnostics    DGX

QUEST DIAGNOSTICS

(DGX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QUEST DIAGNOSTICS : Ex-dividend day for

share with twitter share with LinkedIn share with facebook
07/07/2020 EDT

A dividend is removed today from Quest Diagnostics's share.



© Factset 2020
share with twitter share with LinkedIn share with facebook
Latest news on QUEST DIAGNOSTICS
07/13Analog Devices, AMC fall; Pfizer, Quest Diagnostics rise
AQ
07/13QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
07/13Quest sees Q2 revenue above estimates on demand for COVID-19 testing services
RE
07/13QUEST DIAGNOSTICS INC : Results of Operations and Financial Condition, Financial..
AQ
07/13QUEST DIAGNOSTICS : Announces Preliminary Second Quarter 2020 Financial Results
PR
07/09Wait Times Grow for Covid-19 Test Results as Infections Rise Sharply
DJ
07/07QUEST DIAGNOSTICS : Ex-dividend day for
FA
07/06QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
06/29QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
06/29CEO ROUNDTABLE ON CANCER : Celebrates Employers marking Ten-Year CEO Cancer Gold..
PR
More news
Financials (USD)
Sales 2020 7 853 M - -
Net income 2020 797 M - -
Net Debt 2020 3 495 M - -
P/E ratio 2020 20,6x
Yield 2020 1,87%
Capitalization 15 933 M 15 933 M -
EV / Sales 2019
EV / Sales 2020 2,47x
Nbr of Employees 47 000
Free-Float 61,4%
Chart QUEST DIAGNOSTICS
Duration : Period :
Quest Diagnostics Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUEST DIAGNOSTICS
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 128,25 $
Last Close Price 119,14 $
Spread / Highest target 30,1%
Spread / Average Target 7,65%
Spread / Lowest Target -9,35%
EPS Revisions
Managers
NameTitle
Stephen H. Rusckowski Chairman, President & Chief Executive Officer
Mark J. Guinan Chief Financial Officer & Executive Vice President
Jay G. Wohlgemuth Chief Medical Officer, Senior VP-R&D, Medical
Gabrielle Wolfson SVP, Chief Information & Digital Officer
Gail R. Wilensky Independent Director
Sector and Competitors